National Healthcare AI Stock Analysis
Want to see NHC full AI Analyst Report?
National Healthcare (NHC) AI Stock Analysis
National Healthcare
(NYSE MKT:NHC)
NHC’s strong financial performance is the primary positive factor, supported by improving cash generation and substantial revenue growth. The score is restrained by weaker technical momentum, relatively elevated valuation, declining margins, and increased debt.
National Healthcare (NHC) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $3.25B
- Dividend Yield
- 1.26%
- Average Volume (3M)
- 121.57K
- Price to Earnings (P/E)
- 27.8
- Beta (1Y)
- 0.26
- Revenue Growth
- 5.71%
- EPS Growth
- 12.44%
- Country
- US
- Employees
- 15,278
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
National Healthcare Business Overview & Revenue Model
Company Description
National HealthCare Corporation (NHC) is a prominent provider in the healthcare sector, involved in the operation, management, and service provision for a wide array of elder care and health facilities. Its diverse portfolio includes skilled nursing...
How the Company Makes Money
NHC generates revenue primarily from (1) providing patient care and resident services across its senior care facilities and (2) earning fees for managing healthcare and senior living operations for third parties. 1) Patient care and resident service...
National Healthcare Financial Statement Overview
Summary
Strong revenue growth, positive profitability, improving operating and free cash flow, and a healthy equity base support the score. Declining margins and a substantial increase in debt are the main weaknesses.
Income Statement
78PositiveBalance Sheet
73PositiveCash Flow
82Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.58B | 1.52B | 1.30B | 1.14B | 1.07B | 1.01B |
| Gross Profit | 752.86M | 596.70M | 487.01M | 429.20M | 388.11M | 344.88M |
| EBITDA | 207.86M | 213.72M | 182.53M | 131.10M | 68.28M | 191.56M |
| Net Income | 114.66M | 120.02M | 101.93M | 66.80M | 22.45M | 138.59M |
Balance Sheet | ||||||
| Total Assets | 2.07B | 1.53B | 1.52B | 1.31B | 1.28B | 1.40B |
| Cash, Cash Equivalents and Short-Term Investments | 221.32M | 309.18M | 216.19M | 223.62M | 182.59M | 256.02M |
| Total Debt | 518.37M | 87.07M | 214.77M | 93.39M | 125.94M | 166.66M |
| Total Liabilities | 936.98M | 451.90M | 541.27M | 400.32M | 397.94M | 494.94M |
| Stockholders Equity | 1.12B | 1.07B | 980.16M | 908.75M | 874.28M | 903.00M |
Cash Flow | ||||||
| Free Cash Flow | 175.71M | 148.63M | 79.70M | 83.31M | -21.46M | 23.00M |
| Operating Cash Flow | 221.76M | 185.08M | 107.30M | 111.22M | 8.74M | 62.39M |
| Investing Cash Flow | -671.38M | -33.86M | -236.69M | -17.57M | -5.98M | -65.89M |
| Financing Cash Flow | 384.41M | -135.96M | 100.34M | -42.55M | -47.64M | -35.26M |
National Healthcare Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NHC, the sentiment is Negative. The current price of 207.19 is below the 20-day moving average (MA) of 215.98, below the 50-day MA of 222.58, and above the 200-day MA of 196.88, indicating a neutral trend. The MACD of -5.12 indicates Positive momentum. The RSI at 40.19 is Neutral, neither overbought nor oversold. The STOCH value of 51.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NHC.
National Healthcare Risk Analysis
National Healthcare disclosed 32 risk factors in its most recent earnings report. National Healthcare reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksNational Healthcare Peers Comparison
Overall Rating
ADUS83Outperform
ENSG75Outperform
PACS71Outperform
NHC68Neutral
PNTG61Neutral
BKD47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 83Outperform | $2.32B | 20.71 | 9.81% | ― | 11.53% | 27.72% | |
| 75Outperform | $10.98B | 27.13 | 16.63% | 0.14% | 17.49% | 19.82% | |
| 71Outperform | $7.78B | 27.95 | 25.77% | ― | 11.02% | 62.56% | |
| 68Neutral | $3.25B | 27.83 | 10.41% | 1.26% | 5.71% | 12.44% | |
| 61Neutral | $1.30B | 35.41 | 10.15% | ― | 38.67% | 33.07% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 47Neutral | $2.14B | -56.07 | 88.80% | ― | -8.42% | 87.98% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NHC | National Healthcare | 207.19 | 82.90 | 66.69% | |
| ADUS | Addus HomeCare Corporation | 124.61 | 15.61 | 14.32% | |
| BKD | Brookdale Senior Living Inc. | 8.96 | -1.53 | -14.59% | |
| ENSG | The Ensign | 188.23 | 9.78 | 5.48% | |
| PNTG | Pennant Group Inc | 37.03 | 10.87 | 41.55% | |
| PACS | PACS Group Inc | 49.00 | 32.17 | 191.15% |
National Healthcare Corporate Events
National Healthcare Declares Quarterly Dividend, Signals Ongoing Stability
PositiveOn August 6, 2026, National HealthCare Corporation announced it will pay a quarterly cash dividend of $0.67 per common share, reinforcing its ongoing practice of returning capital to shareholders. The dividend will be paid on October 30, 2026, to sha...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026
